Dr. Suzanne Humphries explains what the flu shot is doing to your immune health.-RJ
Posted by United 4 Truth on Thursday, 30 November 2017
Dr. Suzanne Humphries explains what the flu shot is doing to your immune health.-RJ
Posted by United 4 Truth on Thursday, 30 November 2017
As has been stated before, all medical and non-medical authorities on vaccination agree that vaccines are designed to cause a mild case of the diseases they are supposed to prevent. But they also know and admit that there is no way whatsoever to predict whether the case will be mild or severe – even deadly. With this much uncertainty in dealing with the very lives of people, it is very unscientific and extremely dangerous to use such a questionable procedure as vaccination.
Many vaccines also cause other diseases besides the one for which they are given. For instance, smallpox vaccine often causes syphilis, paralysis, leprosy, and cancer. Polio shots, diphtheria toxin-antitoxin, typhoid vaccine, as well as measles, tetanus and all other shots often cause various other stages of disease such as post-vaccinal encephalitis (inflammation of the brain,) paralysis, spinal meningitis, blindness, cancer (sometimes within two years,) tuberculosis, (two to twenty years after the shot,) arthritis, kidney disease, heart disease (heart failure sometimes within minutes after the shot and sometimes several hours later.) Nerve damage and many other serious conditions also follow the injections.
When several shots are given (different vaccines) within a few days or a few weeks apart, they often trigger intensified cases of all the diseases at once, because the body cannot handle such a large amount of deadly poison being injected directly into the bloodstream. The doctors call it a new disease and proceed to suppress the symptoms.
When poison is taken by the mouth, the internal defense system has a chance to quickly eject some of it by vomiting, but when the poisons are shot directly into the body, bypassing all the natural safeguards, these dangerous poisons circulate immediately throughout the entire body in a matter of seconds and keep on circulating until all the cells are poisoned.
I heard that seven men dropped dead in a doctor’s office after being vaccinated. This was in an army camp, so I wrote to the Government for verification. They sent me the report of U.S. Secretary of War, Henry L. Stimson. The report not only verified the report of the seven who dropped dead from the vaccines, but it stated that there had been 63 deaths and 28,585 cases of hepatitis as a direct result of the yellow fever vaccine during only 6 months of the war. That was only one of the 14 to 25 shots given the soldiers. We can imagine the damage that all these shots did to the men. (See the chapter on What Vaccinations Did to Our Soldiers.)
The first World War was of a short duration, so the vaccine makers were unable to use up all their vaccines. As they were (and still are) in business for profit, they decided to sell it to the rest of the population. So they drummed up the largest vaccination campaign in U.S. history. There were no epidemics to justify it so they used other tricks. Their propaganda claimed the soldiers were coming home from foreign countries with all kinds of diseases and that everyone must have all the shots on the market.
The people believed them because, first of all, they wanted to believe their doctors, and second, the returning soldiers certainly had been sick. They didn’t know it was from doctor-made vaccine diseases, as the army doctors don’t tell them things like that. Many of the returned soldiers were disabled for life by these drug-induced diseases. Many were insane from postvaccinal encephalitis, but the doctors called it shell shock, even though many had never left American soil.
The conglomerate disease brought on by the many poison vaccines baffled the doctors, as they never had a vaccination spree before which used so many different vaccines. The new disease they had created had symptoms of all the diseases they had injected into the man. There was the high fever, extreme weakness, abdominal rash and intestinal disturbance characteristic of typhoid. The diphtheria vaccine caused lung congestion, chills and fever, swollen, sore throat clogged with the false membrane, and the choking suffocation because of difficulty in breathing followed by gasping and death, after which the body turned black from stagnant blood that had been deprived of oxygen in the suffocation stages. In early days they called it Black Death. The other vaccines cause their own reactions — paralysis, brain damage, lockjaw, etc.
When doctors had tried to suppress the symptoms of the typhoid with a stronger vaccine, it caused a worse form of typhoid which they named paratyphoid. But when they concocted a stronger and more dangerous vaccine to suppress that one, they created an even worse disease which they didn’t have a name for. What should they call it? They didn’t want to tell the people what it really was — their own Frankenstein monster which they had created with their vaccines and suppressive medicines. They wanted to direct the blame away from themselves, so they called it Spanish Influenza. It was certainly not of Spanish origin, and the Spanish people resented the implication that the world-wide scourge of that day should be blamed on them. But the name stuck and American medical doctors and vaccine makers were not suspected of the crime of this widespread devastation — the 1918 Flu Epidemic. It is only in recent years that researchers have been digging up the facts and laying the blame where it belongs.
Some of the soldiers may have been in Spain before coming home, but their diseases originated in their own home-based U.S. Army Camps. Our medical men still use that same dodge. When their own vaccines (required for travel) cause vaccine diseases abroad they use this as grounds for a scare campaign to stampede people into the vaccination centers. Do you remember the Hong Kong Flu and the Asian Flu and the London Flu scares? These were all medically-made epidemics mixed with the usual common colds which people have every year.
Now (1976) we are being worked on again by the vaccine -epidemic makers in their effort to force another multi million dollar vaccine sale caper. Their con men have already talked President Ford into handing over $135 million dollars to start their vaccine racket. Even the insurance companies refused to become involved with such an obviously dangerous and crooked scheme. So, again the medical and drug con men induced the appropriate government officials to guarantee insurance against the, possible billions of dollars in law suits which could be brought against the vaccine promoters if the vaccine campaign is carried out as planned. It’s a good thing Ford was voted out of office. It’s too bad he wasn’t “dumped” before he paid the poison squad the MONEY’ to poison the whole population. However, we don’t yet know if President Carter will be any better. Will he be held in the grip of the medical and drug dictatorship? Or will he investigate — learn the truth — reverse the decisions and make the vaccine makers return the money taken from the taxpayers under false pretenses?
The statement of the swine flu vaccine promoters to the effect that the vaccine is harmless, is false, and the statement that it will protect against flu is false. Fifty-six people died after the shots, some within 48 hours. There is confusion and disagreement among the doctors about all aspects of the vaccine, from the safety and effectiveness to the necessity for it, who should have it and who should be warned against it.
Their scare-head campaign cry is that the swine flu is like the 1918 flu which killed 20,000,000 people. They don’t have any usable and provable blood samples from the 1918 flu epidemic to prove it. That was 58 years ago, and the doctors were just as confused and inefficient then as now. However, one thing is certain — the 1918 Spanish Influenza was a vaccine-induced disease caused by extreme body poisoning from the conglomeration of many different vaccines. The soldiers at Fort Dix who were said to have had Swine Flu had been injected with a large variety of vaccines like the vaccines which caused the 1918 flu epidemic. The flu epidemic at Fort Dix was in no way related to swine. There were no swine at camp (unless we want to sarcastically call the vaccine promoters who caused the diseases -“swine.”)
To add to the confusion, the doctors tell the people that there are a lot of various kinds of flu; the one which the soldiers at Fort Dix had was AVictoria flu, there are other strains of flu virus, and also, that the swine flu vaccine which so many people have taken already will not protect them against the many other types of flu. This will be used as an “out” in case of law suits later on when more casualties begin to show up. The doctors will say that the vaccine failed because it was the wrong kind of flu for the vaccine. Of course, no one can prove it one way or the other because viruses are illusive, invisible organisms which are unstable and unpredictable. One dictionary definition of virus is “a morbid poison.” The vaccines injected into the body are poison and cause the typical poison reactions. Virus (poison) does not fly around and attack people.
Therefore, there will be no swine flu epidemic unless the vaccine promoters make one like they did in the 1918 flu epidemic. It will not kill 20,000,000 people unless the people submit to the disease-producing shots. There are also, other causes of disease besides vaccines, such as bad food, which has been devitalized and contaminated with poison preservatives and artificial drug concoctions. There are many more causes of disease but no diseases are contagious.
Vaccine drives come and go as often as the vaccine promoters can cook up the slightest pretense of a reason.n Back in1957 they were trying to stir up a vaccination campaign for what they decided to call Asiatic flu. An editorial in the Herald and Express for August 29, 1957 was captioned, “Fear of Flu Propaganda.” Part of the piece is as follows:
“What a tempest in a teapot has been blown up over the probability that this country will experience an epidemic of the Asiatic flu in the fall and winter months ahead.
“Even the United States Department of Health is stooge for the panic — and has issued statements which are frightening the public, rather than reassuring them by pointing out that this epidemic, while widespread, gives no indication of being any more dangerous than our usual flood of influenza-like colds when winter comes on.
“Those who read between the lines even wonder whether the whole thing might not be a bit of super salesmanship on the part of those who are making and selling the vaccines which are being prepared.. . .”
I WAS AN ON-THE-SPOT OBSERVER OF THE 1918 INFLUENZA EPIDEMIC
All the doctors and people who were living at the time of the 1918 Spanish Influenza epidemic say it was the most terrible disease the world has ever had. Strong men, hale and hearty, one day would be dead the next. The disease had the characteristics of the black death added to typhoid, diphtheria, pneumonia, smallpox, paralysis and all the diseases the people had been vaccinated with immediately following World War 1. Practically the entire population had been injected “seeded” with a dozen or more diseases — or toxic serums. When all those doctor-made diseases started breaking out all at once it was tragic.
That pandemic dragged on for two years, kept alive with the addition of more poison drugs administered by the doctors who tried to suppress the symptoms. As far as I could find out, the flu hit only the vaccinated. Those who had refused the shots escaped the flu. My family had refused all the vaccinations so we remained well all the time. We knew from the health teachings of Graham, Trail, Tilden and others, that people cannot contaminate the body with poisons without causing disease.
When the flu was at its peak, all the stores were closed as well as the schools, businesses — even the hospital, as the doctors and nurses had been vaccinated too and were down with the flu. No one was on the streets. It was like a ghost town. We seemed to be the only family which didn’t get the flu; so my parents went from house to house doing what they could to look after the sick, as it was impossible to get a doctor then. If it were possible for germs, bacteria, virus, or bacilli to cause disease, they had plenty of opportunity to attack my parents when they were spending many hours a day in the sick rooms. But they didn’t get the flu and they didn’t bring any germs home to attack us children and cause anything. None of our family had the flu — not even a sniffle— and it was in the winter with deep snow on the ground.
When I see people cringe when someone near them sneezes or coughs, I wonder how long it will take them to find out that they can’t catch it — whatever it is. The only way they can get a disease is to develop it themselves by wrong eating, drinking, smoking or doing some other things which cause internal poisoning and lowered vitality. All diseases are preventable and most of them are cureable with the right methods, not known to medical doctors, and not all drugless doctors know them either.
It has been said that the 1918 flu epidemic killed 20,000,000 people throughout the world. But, actually, the doctors killed them with their crude and deadly treatments and drugs. This is a harsh accusation but it is nevertheless true, judging by the success of the drugless doctors in comparison with that of the medical doctors.
While the medical men and medical hospitals were losing 33% of their flu cases, the non-medical hospitals such as BATTLE CREEK, KELLOGG and MACFADDEN’S HEALTH-RESTORIUM were getting almost 100% healings with their water cure, baths, enemas, etc., fasting and certain other simple healing methods, followed by carefully worked out diets of natural foods. One health doctor didn’t lose a patient in eight years. The very successful health treatment of one of those drugless doctors who didn’t lose any patients will be given in the other part of this book, titled VACCINATION CONDEMNED, to be published a little later.
If the medical doctors had been as advanced as the drugless doctors, there would not have been those 20 million deaths from the medical flu treatment.
There was seven times more disease among the vaccinated soldiers than among the unvaccinated civilians, and the diseases were those they had been vaccinated against. One soldier who had returned from overseas in 1912 told me that the army hospitals were filled with cases of infantile paralysis and he wondered why grown men should have an infant disease. Now, we know that paralysis is a common after-effect of vaccine poisoning. Those at home didn’t get the paralysis until after the world-wide vaccination campaign in 1918.
This article is excerpt from Swine Flu Expose – a book by Eleanora I. McBean, Ph.D., N.D.
With news that an Aussie Flu is affecting the UK population and that a Swine flu is ravishing India, it is by no coincidence that a new patent has been granted for a `UNIVERSAL` Flu vaccine.
The patent was given by the Indian Government to Pharmaceutical company on 2nd January 2018.
It involves BiondVax which was created by the Israelis. https://www.timesofisrael.com/biondvax-surges-after-results-of-flu-vaccine-study/
Dr. Tamar Ben-Yedidia, CSO of BiondVax, commented, “We are pleased and thankful that the Government of India’s Patent Office accepted the uniqueness of our universal flu vaccine solution and approved this main patent of BiondVax. Authorities worldwide recognise that currently marketed influenza vaccines fall short. I am proud that M-001, which is designed to cover current, future, seasonal and pandemic flu strains, is preparing to enter Phase 3 trials later in 2018.”
It is also reported that the vaccine will be in use in 30 countries.
On August 31, 2017, BiondVax announced its intent to voluntarily delist from the Tel Aviv Stock Exchange (TASE): Dual-Listed BiondVax to Voluntarily Delist from Tel Aviv Stock Exchange
On October 30, 2017, BiondVax announced the last trading date on TASE will be January 18, 2018, and that shares will be delisted from the TASE on January 22, 2018. This announcement was filed with the TASE http://maya.tase.co.il/reports/details/1128530/1/0 and the SEC https://www.sec.gov/Archives/edgar/data/1611747/000121390017011053/f6k103017_biondvaxpharma.htm.
The company announced in August 2017 that it will delist from the stock exchange January 2018. Delisting usually means that they have been bought out by a private equity firm.
Nes Ziona, Israel – February 26, 2014 – BiondVax Pharmaceuticals Ltd (TASE: BNDX), developer of a universal flu vaccine, announced today that the Company has just returned from a meeting with officials at the Biomedical Advanced Research and Development Authority/Health and Human Services (BARDA/HHS) at which clinical trial results for BiondVax’s universal flu vaccine, the Multimeric 001, was presented. BiondVax was invited to give this seminar to the Influenza Division at BARDA, during which the Company’s solution for global pandemic flu outbreaks was discussed. At the meeting the Company was informed that BARDA will consider proposals to provide pandemic vaccines and funding of clinical trials examining the usage of BiondVax’s universal flu vaccine as a primer that provides preparedness ahead of pandemic flu outbreaks. In addition, at the seminar the Company discussed the use of its vaccine as a standalone universal flu vaccine.http://www.biondvax.com/2014/02/biondvax-meets-with-the-us-biomedical-advanced-research-and-development-authority-barda-to-present-the-use-of-its-universal-flu-vaccine-against-global-pandemic-influenza-outbreak/
And before any Safety trails begin?
Nes Ziona, Israel – February 10th , 2014 – BiondVax (TASE: BNDX), developer of a universal flu vaccine, announced receiving approval from Hong Kong’s patent office to register its patent concerning Multimeric Multiepitopes for the Company’s universal flu vaccine, as well as an approval from the US patent office for the completion of the testing process for patent registration. As part of the US registration process, the patent was found eligible and currently is pending fees. The patent addresses the vaccine structure and composition as well as the manufacturing methods and the usages of the universal flu vaccine, while providing scope for possible changes in the structure of the protein that is the basis for the universal vaccine. The patent extends and secures the coverage provided by existing patents that protect BiondVax’s intellectual property.
These approvals in Hong Kong and the US build on patent approvals already received in Australia, China, Russia and Mexico. In parallel, the Company is in the process of registering the patent in other locations worldwide such as Europe and Israel. http://www.biondvax.com/2014/02/biondvax-receives-patent-registration-approval-for-multimeric-multiepitope-influenza-vaccines-in-hong-kong-as-well-as-allowance-of-patent-registration-in-us-for-the-companys-universal-flu-vac/
Reports even claim that it can cover strains which do not exist!
Ness Ziona, Israel – January 12, 2017
BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV), developer of the Universal Flu Vaccine candidate M-001, reports the publication this week of an article titled, “Back to the future: Immunization with M-001 prior to trivalent influenza vaccine in 2011/12 enhanced protective immune responses against 2014/15 epidemic strain” in the prestigious peer-reviewed scientific journal Vaccine.
Dr. Tamar Ben-Yedidia, BiondVax’s Chief Scientist and co-inventor of M-001, commented, “We consider this study to provide validation of M-001’s potential. It is a promising indication that our vaccine may provide improved protection against future flu strains, including potentially pandemic strains that don’t yet exist!” http://www.biondvax.com/2017/01/back-to-the-future-study-published-in-vaccine-journal-indicates-biondvaxs-universal-flu-vaccine-candidate-may-cover-strains-which-dont-yet-exist/
So there we have it! A miracle vaccine that was granted patents even before it was tested, that can cure all strains of flu world wide, even those that do not yet exist and is being stockpiled for the next pandemic!
By Jacob Puliyel
The writer, a doctor, is the Head of Pediatrics, St Stephen’s Hospital, Delhi, and a member of the National Technical Advisory Group on Immunisation. The views expressed are personal.
Before a new vaccine is introduced it is first studied in a randomised controlled trial where some are given the drug and others are given an inert substance to check the effects and adverse effects among those given the new drug. Last week, Slate published a cover story on the investigation of the randomised trials of human papillomavirus (HPV ) vaccines before approval. The science editor conducted an eight-month long investigation, interviewed study participants and studied 2,300 pages of documents obtained through freedom-of-information requests from hospitals and health authorities.
Slate found that during the year-long study data on potential side effects were collected for only two weeks. The rest of the time individual trial investigators used their personal judgment to decide whether or not to report medical problems as adverse events. An oxymoronic instruction to investigators was to list new problems as ‘new medical history’. There is no evidence the confidential study protocol was submitted to regulators for approval. The worksheet investigators used allotted just one line per entry for new medical history, with no measurement of symptom severity, duration, outcome, or overall seriousness. Trial participants complained to Slate that repeated complaints of debilitating symptoms were not even registered in the study as potential side effects. The European Medicines Agency (EMA) is the regulator in Europe. In an internal 2014 EMA report about Gardasil 9 – a leading HPV vaccination – obtained through a freedom-of-information request, senior experts called the company’s approach “unconventional and suboptimal” and said it left some “uncertainty” about the safety results. In the EMA’s public assessment Gardasil 9, all mention of the safety concerns had been scrubbed.
Chronic Fatigue Syndrome
Not all recipients of the vaccine developed serious adverse effects. But there are numerous reports of chronic fatigue syndrome (CFS ) otherwise known as myalgic encephalomyelitis which is characterized by long-term fatigue that limits a person’s ability to carry out ordinary daily activities. Dr Jose Montoya, a professor of medicine at Stanford University explains that the condition usually starts with an insult to the immune system—a severe infection, a car crash, a pregnancy. The first symptoms are flu-like, but months go by and the patient realizes she isn’t getting better.’ In a few genetically predisposed individuals, Montoya told the Slate editor, it is “biologically plausible” that the vaccine, which mimics a natural infection, could also trigger an immune response powerful enough to lead to CFS. To find out if that is the case, trial investigators would need to carefully track participants’ symptoms “for at least one year.” CFS is not the only serious adverse effect reported. The American College of Pediatrics has suggested one of the HPV vaccines could possibly be associated with the very rare but serious condition of premature ovarian failure (POF), also known as premature menopause. In Japan, use of the vaccine in adolescents has been associated with such serious adverse events that it has been withdrawn from the immunisation programme.
Usefulness of Vaccine
HPV spreads only through sexual contact and therefore is not communicable in a casual manner. There are about 100 strains of HPV, and the vaccine only protects against 2, 4, or 9 of them, depending on the brand and 95% of HPV infections heal by themselves – potentially granting the individual lifetime immunity against the particular strain. Perhaps to improve uptake of the vaccine the manufacturers promote it as an anticancer vaccine rather than a vaccine against sexually transmitted disease. But while there is evidence that the vaccine reduces infection with the vaccine strains of the virus, non-vaccine strains have been known to replace the vaccine strain and these could produce cancer. There is currently no scientific study that shows the vaccine reduces cervical cancer in the women who are vaccinated. The efficacy of the vaccine against cancer is unknown
Cost-effectiveness READ MORE HERE.
Also published, 12/25 in the Tribune India was the following:
CN Purandare, Alka Kriplani & Neerja Bhatla IN India, cervical cancer is the second most common cancer in women, accounting for nearly one-fourth of the global burden of cervical cancer, with an estimated 122,800 new cases and 67,500 deaths annually, which is more than the number of deaths due to maternal mortality. Since these women are usually in their 40s and 50s, it is estimated that the years of life lost are greater in cervical cancer. Globally, cervical cancer accounts for 528,000 cases including 445,000 cases in low and middle income countries (LMICs).
The age-standardised incidence rate of cervical cancer varies between 5.6 and 24.3 per 100,000 women in different regions of India. Although a gradually declining trend in the cervical cancer incidence has been observed in different regions of India over the last two decades, the rates still remain significantly higher than in other Asian countries. In fact, the absolute numbers of both cervical cancer cases and deaths are on the increase due to population growth. In the West, repeated testing by Pap smear and consequent treatment of precancerous lesions led to a substantial decline in the numbers of cervical cancer cases. In India, with very limited resources to introduce and sustain effective population-based cervical cancer screening programs, there was not much progress in preventing this very preventable cancer. The discovery by Nobel laureate Harald zur Hausen that persistent infection with one of the oncogenic, high-risk types of human papillomaviruses (HPV) is the ‘necessary’ cause of cervical cancer; enabled the development of primary prevention using HPV vaccination. Presently available vaccines target the two types that are responsible for 70 per cent of cervical cancers worldwide. HPV 16 and HPV 18 and can prevent over 90 per cent of high-grade precancerous lesions caused by these types. In India, there is a greater proportion of these types, making it likely that the impact of vaccination will be better than has been observed already in research studies and in countries that have implemented the vaccine program.
Efficacy of doses
Fewer than three doses of HPV vaccine would substantially reduce costs, improve compliance, ease logistics and facilitate scale up in national immunization programs. Data to support this has emerged from trials. WHO, after reviewing the available evidence on less than 3-doses, has recommended a two-dose schedule for girls (at an interval of 6 months, which may be extended to 12 months to facilitate vaccination) if vaccination is initiated prior to 15 years of age and a three-dose schedule (at 0, 1-2, and 6 months) if vaccination is initiated after the 15th birthday and for immunocompromised individuals, including those infected with HIV.
Countries implementing Immunisation
More than 80 countries have introduced HPV vaccine in the national immunisation programs (NIPs), of which 33 are LMICs; in addition, 25 LMICs have introduced HPV vaccination in pilot demonstration programs as a prelude to national scaling up in NIPs. In most programs a school-based approach is predominantly used to deliver the vaccine to the targeted adolescents with additional efforts using field clinics, and primary health centres to cover girls who missed vaccination and do not attend schools. Gavi The Vaccine Alliance has been able to markedly reduce the procurement price of both vaccines to Rs $5. While Australia, Denmark, USA and Canada were the first high-income countries to introduce HPV vaccination in NIPs in 2007, Panama (2008) in Latin America, Bhutan (2009) in Asia and Rwanda (2010) in Africa were the first LMICs that introduced HPV vaccination. Early reports of protection offered by the vaccine at the population level against vaccine targeted HPV infections, genital warts and cervical premalignant lesions have already started coming from countries that introduced the vaccine between 2007 and 2010.
HPV vaccine safety
Extensive data on the safety of HPV vaccines are now available from clinical trials and the population programs. Globally more than 270 million doses have been administered with no serious adverse events linked to the HPV vaccine and with an excellent safety profile. A meta-analysis of vaccine trials concluded that the frequency of serious adverse events (OR 0.99; 95%CI 0.87-1.14) and death (OR 0.91, 95%CI 0.39-2.14) were similar in the vaccinated and control groups. The majority of deaths reported were accidental in nature, and none was attributable to the vaccines. Various rare syndromes have also been studied and none found to be related to the vaccine. A recently published study from India reported no serious adverse event attributable to the vaccine after administering 34,856 doses of the quadrivalent vaccine to 10-18 year old girls and following them over four year.
Regulators froze the Philippines’ world-first public dengue immunisation programme last week and suspended all sales of the vaccine on Monday after Sanofi said Dengvaxia could worsen symptoms for vaccinated people who contracted the disease for the first time.
“Eventually it’s the court of law that is going to decide in so far as the liability of Sanofi is concerned,” Health Secretary Francisco Duque said on ABS-CBN television
The previous administration of President Benigno Aquino launched the vaccination programme last year, making the Philippines the first nation to use Dengvaxia on a mass scale.
About 830,000 schoolchildren had received at least one dose of the vaccine, Duque said on Thursday. Previously the government said more than 733,000 people had been vaccinated.
Sanofi’s announcement last week caused great concern in the Philippines – where the mosquito-born disease is extremely prevalent.
Federal officials on Tuesday ended a moratorium imposed three years ago on funding research that alters germs to make them more lethal.
Such work can now proceed, said Dr. Francis S. Collins, the head of the National Institutes of Health, but only if a scientific panel decides that the benefits justify the risks.
Some scientists are eager to pursue these studies because they may show, for example, how a bird flu could mutate to more easily infect humans, or could yield clues to making a better vaccine.
Critics say these researchers risk creating a monster germ that could escape the lab and seed a pandemic.
Now, a government panel will require that researchers show that their studies in this area are scientifically sound and that they will be done in a high-security lab.
The pathogen to be modified must pose a serious health threat, and the work must produce knowledge — such as a vaccine — that would benefit humans. Finally, there must be no safer way to do the research.
“We see this as a rigorous policy,” Dr. Collins said. “We want to be sure we’re doing this right.”
In October 2014, all federal funding was halted on efforts to make three viruses more dangerous: the flu virus, and those causing Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS).
But the new regulations apply to any pathogen that could potentially cause a pandemic. For example, they would apply to a request to create an Ebola virus transmissible through the air, said Dr. Collins.
There has been a long, fierce debate about projects — known as “gain of function” research — intended to make pathogens more deadly or more transmissible.
In 2011, an outcry arose when laboratories in Wisconsin and the Netherlands revealed that they were trying to mutate the lethal H5N1 bird flu in ways that would let it jump easily between ferrets, which are used to model human flu susceptibility.
Tensions rose in 2014 after the Centers for Disease Control and Prevention accidentally exposed lab workers to anthrax and shipped a deadly flu virus to a laboratory that had asked for a benign strain.
That year, the N.I.H. also found vials of smallpox in a freezer that had been forgotten for 50 years.
When the moratorium was imposed, it effectively halted 21 projects, Dr. Collins said. In the three years since, the N.I.H. created exceptions that funded ten of those projects. Five were flu-related, and five concerned the MERS virus.
That virus is a coronavirus carried by camels that has infected about 2,100 peoplesince it was discovered in 2012, and has killed about a third of them, according to the World Health Organization.
Critics of such research had mixed reactions. “There’s less than meets the eye,” said Richard H. Ebright, a molecular biologist and bioweapons expert at Rutgers University.
Although he applauded the requirement for review panels, he said he would prefer independent panels to government ones.
He also wanted the rules to cover all such research rather than just government-funded work, as well as clearer minimum safety standards and a mandate that the benefits “outweigh” the risks instead of merely “justifying” them.
Marc Lipsitch, an epidemiologist who directs the Center for Communicable Disease Dynamics at the Harvard School of Public Health, called review panels “a small step forward.”
Recent disease-enhancing experiments, he said, “have given us some modest scientific knowledge and done almost nothing to improve our preparedness for pandemics, and yet risked creating an accidental pandemic.”
Therefore, he said, he hoped the panels would turn down such work.
Michael T. Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota, said he believed some laboratories could do such work safely, but wanted restrictions on what they could publish.
“If someone finds a way to make the Ebola virus more dangerous, I don’t believe that should be available to anybody off the street who could use it for nefarious purposes,” he said.
“Physicists long ago learned to distinguish between what can be publicly available and what’s classified,” he added, referring to nuclear weapons research. “We want to keep some of this stuff on a need-to-know basis.”https://www.nytimes.com/2017/12/19/health/lethal-viruses-nih.html
Go Fund Me
Note: We’re delighted to share this post by Martin Walker. Martin covered the GMC trial in the UK moment by moment and is a copious author whose book “Dirty Medicine” is sharp and thought provoking. Please visit his website Slingshot Publications. Ordering information is at the bottom of this post.
By Martin Walker
Just this morning I saw Robert Kennedys meme about the control of the CDC by pharmaceutical companies and pharmaceutical company licensing. The situation is not quite the same in the UK but his statement ‘The CDC is not an independent agency, it is a vaccine company’ rang bells with me.
By infiltration the pharmaceutical companies have take over completely the regulation of pharmaceutical medicines in the UK. The most powerful of the groups involved is the Medicines and Healthcare Regulatory Agency, (MHRA), like the CDC the agency, responsible for licensing. Most people in Britain see the Agency as part of the UK government with a supportive civil service. However the MHRA, although apparently attached to the UK government, is actually a free standing ‘executive agency’.
The Agency employs more than 1,200 people and has facilities in London, York and South Mimms, Hertfordshire. It deals with the licensing of all drugs and has various departments which carry the pharmaceutical cause further. The group also has ex-police investigators there to harry alternative medicine practitioners and bring charges against them if necessary, and a small unit which sends out letters under the names of fictitious patients asking for information on alternative treatments. The executive Agency is wholly funded by the pharmaceutical industry.
Although the pharmaceutical companies pay the whole bill for the MHRA, there are occasions when the MHRA sees fit to make a criminal prosecution – yes the MHRA has the power to prosecute in criminal law – against an alternative health distributor or practitioner. Clearly it would be unfair to expect the pharmaceutical companies to pay for such cases, so when they do bring them, despite the fact that they do not pass through the Crown Prosecution Service (the governemt check on the validity of cases) they draw on the common purse getting the tax payer to fund their case.
The agency is run by a management board at present headed by Dr Ian Hudson who became chief executive in September 2013. Hudson is a physician who practiced as a paediatrician for a number of years, before working in the pharmaceutical industry in clinical research and development between 1989 and 2001, at which time he joined the Medicines Control Agency (former organisation to the MHRA) as director of its licensing division.
The head since 2014 of the licensing division, the most inbred of departments, which receives the majority of funding for MHRA from drug companies desperate to get their drugs licensed, is Dr Siu Ping Lam who the MHRA site assures us, has over 24 years’ experience in medicines regulation.
Dr Siu Ping Lam the MHRA site claims, has shaped many changes in European directives for pharmaceuticals, set up the traditional herbal medicines registration scheme, and the homeopathic medicines registration scheme.
A third member of the MHRA Board, worth noting is Gerald Hedell a microbiologist who is a Chartered Biologist and a member of the Society of Biology and the Royal Society of Chemistry. Hedell, previously worked for the National Health Service (NHS) but left in 1978, since then Hedell has worked in senior roles for the late Wellcome Foundation, Glaxo Wellcome and GlaxoSmithKline.
How the MHRA came into being is instructive. The Evans Cunliffe report, Study of Control of Medicines, published in 1987 written by a senior civil servant at the Department of Health with an ICI chemicals executive, a leading member of the Association of British Pharmaceucal Industries (ABPI), acknowledged the cosy, informal relationship between ‘officials’ in the DoH and ‘applicant companies’ seeking to license their products.
The report – that had come about because of the massive backlog of chemicals, drugs and apparatus in need of licences, which were piling up on the books of the Medicines Division – determined this informal co- operation to be a healthy state of affairs, which had regrettably been lost over the years. The report recommended that there was a return to this ‘informal communication’ between parties and that ‘both parties should take steps to encourage informal communication’.
DHSS (Department of Health and Social Security) and the pharmaceutical industry agree that communication between officials and applicant companies has become more formal in recent years, with more reliance on written notices referring to the terms of the Medicines Act. All parties agree the need for informal communication by telephone, letter and meetings help to remove misunderstanding and aid the smooth dispatch of business. (22)
This report signalled the first momentum in modern British history that ushered corporations into the structure of the Government’s civil service.
In order to solve the ‘backlog of licencing’ problems, a department in the DHSS was designated for the pharmaceutical companies, who would fund 60% of its cost. Within a short time, this was a booming ‘department of Government’, running all aspects of regulation and licensing of pharmaceuticals and paid for in its entirety, by licensing fees, by the ABPI and separate pharmaceutical companies.
Just as with the CDC, governments have left the pharmaceutical regulators to get on with their own business. Throughout the 1980s and 1990s there was constant sniping from the media, usually restricted to the minor question of the involvement of those within the wide ranging committees of the MHRA with vested inters. The much larger question, however, of who controls pharmaceutical licensing, has been left entirely to the pharmaceutical companies.
See Martin’s Facebook page for”Dirty Medicine” (here) to learn more about Martin Walker’s books. To order please contact: NEXUS Magazine, 55 Queens Road, East Grinstead, RH19 1BG, UK Tel (+44) 01342 322854 Fax (+44) 01342 324574. Email firstname.lastname@example.org *Single copy purchases can also be made at Amazon.co.uk – look for seller ‘NEXUS Magazine UK’. **Minimum two copies per title for wholesale pricing; to keep costs to a minimum send us your order and we’ll quote for postage.
The science behind a depopulation agenda
A company called INOVIO had been given a $45 million contract by DARPA, the research arm of the Dept of Defence, to pursue Ebola vaccines and the methods of delivery. They were also given a $28 million grant by the N.I.H. They were also involved in vaccines trials for the Zika virus.
The company were given awards for a new start up company, but, this company has a long history with links to government agencies, pioneers of DNA technology and many Pharmaceutical companies.
The following research is alarming to say the least.
In the beginning
In the beginning, Dr Joseph Kim created a partnership with his University professor. Professor Weiner was a pioneer of genetically modified DNA.
He was also heavily involved in HIV and is a pioneer.
It should be noted that soon after Polio experimental vaccines were given to tens of millions in Africa, during the 50,s and 60s, that HIV first began.
They began in 2000 as VGX Pharmaceutical Inc manufacturing plasmid DNA, they had three failed trials in three years,they then worked with Advisys which was an animal lab and used their new DNA technology for creating a synthetic Porcine growth hormone for Pigs.
This enabled them to increase the breeding age of pigs and was soon taken up by the farming industry.
Using PCV2 which is Porcine Circovirus, they are able to use their new technique called Electroporation for the first time, they were pioneers in animal health division.
During this time, the swine flu vaccine patent was first filed, which was not patented until 2009, just 5 months after this was patented, swine flu was being rolled out as the next pandemic.
He was employed by Merck who paid for his Phd and now boasts having people such as the former President of Merck , Adel Mahmoud, on his board, Morton Collins, who served as technology policy advisor to President G.H.W Bush and former Senior Vice president of of Merck, Ford Hutchinson as a scientific advisor who is also a Wellcome trust advisor and was involved in many controversial drugs like Gardasil and Rotateq.
Dr Kim has openly stated that his company has many of his friends and colleagues on the scientific board and on the board of directors.
Rotateq was licensed in 2006 and found to contain both PCV1 and PVC2 and Rotarix which was manufactured by GSK in 2008 was found to contain PVC1.
Both of these vaccines were found to have contained PCV in 2010, years after they had been first given the go-ahead by the FDA. Both were also suspended when the evidence came to light only to be re-instated as safe two months later.
Curiously an online medical search engine called Medworm, which informs details of medical resources and data, published this information on the day that the FDA suspended the vaccines. The writer of that Information was Dr Joseph Kim.
At this point it should be noted that the FDA had failed to spot the pig virus in the initial tests, but then, had also deemed it safe to carry on with this vaccine. Where was the enquiry asking how pig DNA could find its way into vaccine that were supposed to be for diarrohea?
Given that many PCV2 is a post weaning multi system wasting disease which was an emerging disease of swine/pigs how could the FDA even know how safe it was?
Given that this was the exact PCV that Dr Kim was working on, maybe someone should be asking him these question?
It cannot be denied that he was aware of this development, given that it was he, who informed the world of the FDA decision on the very day that the FDA announced this.
At this point, I would like to turn your attention to his partner, Dr Weiner.
An advisor to GSK, Pfizer and other Pharma giants, he is also a special employee and advisor to the FDA and the NIH grant review process.
No wonder then, how Inovio was given a 28 million dollar grant by the NIH to develop its genetically modified DNA based monoclonal antibodies and its new process of electroporation.
This is the process by which the very first genetically modified virus was used in this case, it was on pigs.
In 2006 VGX were providing HIV vaccines in Africa.
In 2008, VGX, which is also owned by Inovio, went into an arrangement to manufacture DNA plasmid for human use.
In 2009, Inovio filed a IND with FDA to start trials on humans with a DNA vaccine for H5N1.
Their lead drug for Swine flu was licensed in 2009.
In 2010, 8 different plasmids were produced in a study provided by the Defence threat Reduction Agency of the DoD.
In 2011 they were working with Homeland security on Foot and mouth disease.
New strains of foot and mouth disease began in 2012 in USA.
Under a research and development agreement, they were working with US Dept of homeland security and Plum Island Animal disease centre.
This does not sound like a company that should be getting awards for a new start up company!
They were then given the go ahead to produce not only the Ebola vaccines but also the new novel method to administer them.
This is a pulsed electrical current applied to local tissue to allow the cell to have holes in it to allow just enough synthetic DNA to enter, then the pulse stops and the cell closes, the problem here is that according to studies, a manuscript in Molecular therapy with references from 74 separate articles written in 2004, concludes that the use of gene transfer using electroporation should only be used with human antibodies because problems could arise from cancer to death.
There is a brief explanation on how ‘recombinant DNA technology’ can influence “A HOST’S DNA” which is why this report was generated to begin with, as it looked into the ‘then’ Soviet Union’s capabilities at that time. A link here shows that:https://gdsajj.wordpress.com/2009/11/
Recombinant DNA encompasses only one area of genetic engineering; namely, Biospecific biochemical and microbiological to alter,relatively controlled and reasonably predictable manner, the molecules that encode the genetic characteristics of an organism, and to introduce specifically selected new set of genetic Instructions.
The specific molecular manipulations that are made and the exact methods used to make them can vary widely from one recombinant DNA experiment to another. The basic process,usually involves the Initial isolation or synthesispecific set of chemically identical nucleic acid molecules (usually molecules are then bonded…?) specially prepared vector (carriers) that usually are plasmids. bacteriophages, or other virus-like infectious entities that can self-replicate in appropriate host cells. After the bonding has been completed, the modified can be inserted into bacteria or other cells that lave been prepared biochemically to accept them. If the vectors have been “constructed” appropriately, the piece of initially selected DNA can give the recipient new genetic instructions. For Instance, the host cell might be given the capability to synthesise an enzyme that it previously could not make.
It goes on to state that:
This science is exactly what you would need for a population reduction ‘PROGRAM’ using ‘mandated’ vaccine legislation! Poisoning the well i.e. GMO food could also work well with this science achieving population reduction quotas. Link shown. https://gdsajj.wordpress.com/2009/11/
Beside the fact that Dr Kim has also served his five year tenure as a member of the Global Agenda Council of the World Economic Forum, which is clearly a huge advocate of a one world global government, attended by the world,s top 1000 corporations and involves a network of Government leaders.
If this man has the capability to create synthetic viruses which they intend to inject into peoples cells to create an immune response, what would happen if the same synthetic virus was put into a vaccine and injected into the blood?
Would the body then react as though it was fighting a real virus, thus creating the cytokine storm that is the very thing that would cause death?
We were informed via the mainstream media that the only way to test for Ebola was for those tests to be sent to UK/US labs, yet, a new piece of equipment has now been produced that allows those tests to be achieved in minutes, but, this appears to have been known and available since 2010, why has it been suppressed by the medical profession, it was part created by Wellcome, who are heavily involved in the medical agenda being played out.
I think the evidence gathered here brings a lot of scientific, military, bio-companies and government organisations into question on ethics and also on their real agenda.http://www.hartford-hwp.com/archives/45/298.html
GSK, the company involved in the Ebola vaccines, planned to axe 900 jobs in the Research Park Triangle in US, this was announced at the beginning of Dec, then a plane crashed, killing all three members on board and three others. I find it extraordinary that the people on board all worked for the Research Park Triangle, in high up positions and were on their way to an important meeting with the FDA!
One man who died was named David Hartman, he was Vice President of a company called Nuventra, they also used to be called Kinetigen and before that ClinPharm Consulting, the President and CEO are ex GSK members.
The company designed a tool to interpret important data that the FDA uses for evaluating market approval, they were heavily involved in the Ebola business and I found a link that suggested that Nuventra had new technology that aimed to make Ebola virus breath tests possible!
Now that would have certainly put paid to the need for vaccines, wouldn’t it!
The next guy was named Dr Michael Rosenberg, he also worked within this same Research Park triangle in research and development, the same area that GSK planned to cut 900 jobs from, a decision made in early Dec 2013.
His job was to ensure the availability of immediate actionable data during clinical trials, he was president and CEO of a company called Health Decisions and was a former CDC chief Defense Technician engineer.
The third man named Chijioke Ogbuka was a Project manager.
450 of the 900 jobs in Research and Development are to be in a GSK focused group within another company called Parexel.
This is a very interesting article, it shows that the man killed in the plane crash, Dr Rosenberg, had created a system whereby the results for approvals and withdrawals of any particular vaccine could be established in a short space of time, now, given that he was on his way to a very important meeting with the FDA and had his project manager on board, I would suggest that this man was killed before he brought the proof that the Ebola vaccines were useless or caused other problems or both!, two days after his death, the USD Health and Human services give immunity to drug companies! http://www.newsobserver.com/news/local/community/durham-news/article10189958.html
This is the data the drug industry do not want you to see.
Here 2 centuries of UK, USA and Australian official death statistics show conclusively and scientifically modern medicine is not responsible for and played little part in substantially improved life expectancy and survival from disease in western economies.